RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma

Cancer Research

Volumn 71, Issue 13, 2011, Pages 4598-4607

  Arai, Akihito ^a,b   Chano, Tokuhiro ^a   Futami, Kazunobu ^c   Furuichi, Yasuhiro ^c   Ikebuchi, Kaichiro ^b   Inui, Takuma ^a   Tameno, Hitosuke ^b   Ochi, Yasuko ^b   Shimada, Taketoshi ^b   Hisa, Yasuo ^b   Okabe, Hidetoshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c GeneCare Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; RECQ HELICASE; RECQL1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WERNER SYNDROME PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER THERAPY; CARCINOMA CELL; CELL GROWTH; CONTROLLED STUDY; DNA RECOMBINATION; DNA REPAIR; DRUG TARGETING; FEMALE; GENE REPRESSION; GENE SILENCING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL DEATH; CELL LINE, TUMOR; CISPLATIN; COMBINED MODALITY THERAPY; EXODEOXYRIBONUCLEASES; GENE SILENCING; HEAD AND NECK NEOPLASMS; HELA CELLS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MICE; MICE, INBRED BALB C; MOLECULAR TARGETED THERAPY; NEOPLASMS, SQUAMOUS CELL; RANDOM ALLOCATION; RECQ HELICASES; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79959903572     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-0320     Document Type: Article

References (50)

1. Yan M, Xu Q, Zhang P, Zhou X, Zhang Z, Chen W. Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma. BMC Cancer 2010;10:437.
2. Bornstein S, White R, Malkoski S, Oka M, Han G, Cleaver T, et al. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest 2009;119:3408-19.
3. Gourin C, Johnson J. A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck. Laryngoscope 2009;119:2124-34.
4. Matsui M, Kishida T, Nakano H, Yoshimoto K, Shin-Ya M, Shimada T, et al. Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. Cancer Res 2009;69:2523-30.
5. Futami K, Kumagai E, Makino H, Goto H, Takagi M, Shimamoto A, et al. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Cancer Sci 2008;99:71-80. (Pubitemid 350239033)
6. Kawabe T, Tsuyama N, Kitao S, Nishikawa K, Shimamoto A, Shiratori M, et al. Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene 2000;19:4764-72.
7. Mao F, Sidorova J, Lauper J, Emond M, Monnat R. The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage. Cancer Res 2010;70:6548-55.
8. Bernstein KA, Gangloff S, Rothstein R. The RecQ DNA helicases in DNA repair. Annu Rev Genet 2010;44:393-417.
9. Popuri V, Bachrati CZ, Muzzolini L, Mosedale G, Costantini S, Giacomini E, et al. The Human RecQ helicases, BLM and RECQ1, display distinct DNA substrate specificities. J Biol Chem 2008;283:17766-76.
10. Shimamoto A, Sugimoto M, Furuichi Y. Molecular biology of Werner syndrome. Int J Clin Oncol 2004;9:288-98. (Pubitemid 39277924)
11. Futami K, Ishikawa Y, Goto M, Furuichi Y, Sugimoto M. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Cancer Sci 2008;99:843-8. (Pubitemid 351997583)
12. Seki M, Otsuki M, Ishii Y, Tada S, Enomoto T. RecQ family helicases in genome stability: lessons from gene disruption studies in DT40 cells. Cell Cycle 2008;7:2472-8.
13. Kobayashi J, Okui M, Asaithamby A, Burma S, Chen B, Tanimoto K, et al. WRN participates in translesion synthesis pathway through interaction with NBS1. Mech Ageing Dev 2010;131:436-44.
14. Sharma S, Stumpo D, Balajee A, Bock C, Lansdorp P, Brosh RJ, et al. RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability. Mol Cell Biol 2007;27:1784-94.
15. Park J, Betel D, Gryfe R, Michalickova K, Di Nicola N, Gallinger S, et al. Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites. Cancer Res 2002;62:1284-8. (Pubitemid 34407779)
16. Futami K, Kumagai E, Makino H, Sato A, Takagi M, Shimamoto A, et al. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models. Cancer Sci 2008;99:1227-36. (Pubitemid 351676636)
17. Futami K, Takagi M, Shimamoto A, Sugimoto M, Furuichi Y. Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase. Biol Pharm Bull 2007;30:1958-61. (Pubitemid 47607770)
18. Ueno M. Roles of DNA repair proteins in telomere maintenance. Biosci Biotechnol Biochem 2010;74:1-6.
19. Crabbe L, Verdun R, Haggblom C, Karlseder J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 2004;306:1951-3. (Pubitemid 39627862)
20. Lebel M, Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc Natl Acad Sci U S A 1998;95:13097-102. (Pubitemid 28509530)
21. Ichikawa K, Noda T, Furuichi Y. [Preparation of the gene targeted knockout mice for human premature aging diseases, Werner syndrome, and Rothmund-Thomson syndrome caused by the mutation of DNA helicases]. Nippon Yakurigaku Zasshi 2002;119:219-26.
22. Agrelo R, Cheng WH, Setien F, Ropero S, Espada J, Fraga MF, et al. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci U S A 2006;103:8822-7. (Pubitemid 43878103)
23. Aggarwal M, Sommers JA, Shoemaker RH, Brosh RM. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress. Proc Natl Acad Sci U S A 2011.
24. Shiratori M, Sakamoto S, Suzuki N, Tokutake Y, Kawabe Y, Enomoto T, et al. Detection by epitope-defined monoclonal antibodies of Werner DNA helicases in the nucleoplasm and their upregulation by cell transformation and immortalization. J Cell Biol 1999;144:1-9. (Pubitemid 29047006)
25. Roninson I, Broude E, Chang B. If not apoptosis, then what? Treatment- induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001;4:303-13. (Pubitemid 34456384)
26. Kastan M, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004;432:316-23. (Pubitemid 39551659)
27. Huang X, Tran T, Zhang L, Hatcher R, Zhang P. DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. Proc Natl Acad Sci U S A 2005;102:1065-70. (Pubitemid 40170726)
28. de Bruin E, Medema J. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev 2008;34:737-49.
29. Topping R, Wilkinson J, Scarpinato K. Mismatch repair protein deficiency compromises cisplatin-induced apoptotic signaling. J Biol Chem 2009;284:14029-39.
30. Vakifahmetoglu H, Olsson M, Tamm C, Heidari N, Orrenius S, Zhivotovsky B. DNA damage induces two distinct modes of cell death in ovarian carcinomas. Cell Death Differ 2008;15:555-66. (Pubitemid 351267306)
31. Thomas C, Strom A, Lindberg K, Gustafsson J. Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G(2)/M checkpoint signaling. Breast Cancer Res Treat 2010.
32. Yu D, Wang C, Shi H, Li Z, Pan L, Yuan Q, et al. Enhancement of cisplatin sensitivity in lewis lung carcinoma by liposome-mediated delivery of a survivin mutant. J Exp Clin Cancer Res 2010;29:46.
33. Castillo-Avila W, Piulats J, Garcia Del Muro X, Vidal A, Condom E, Casanovas O, et al. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors. Clin Cancer Res 2009;15:3384-95.
34. Zhang P, Zhang Z, Zhou X, Qiu W, Chen F, Chen W. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer 2006;6:224.
35. Poot M, Yom J, Whang S, Kato J, Gollahon K, Rabinovitch P. Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J 2001;15:1224-6.
36. Okada M, Goto M, Furuichi Y, Sugimoto M. Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol Pharm Bull 1998;21:235-9. (Pubitemid 28166909)
37. Constantinou A, Tarsounas M, Karow J, Brosh R, Bohr V, Hickson I, et al. Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep 2000;1:80-4.
38. Dhillon KK, Sidorova J, Saintigny Y, Poot M, Gollahon K, Rabinovitch PS, et al. Functional role of the Werner syndrome RecQ helicase in human fibroblasts. Aging Cell 2007;6:53-61. (Pubitemid 46140140)
39. Perry JJ, Asaithamby A, Barnebey A, Kiamanesch F, Chen DJ, Han S, et al. Identification of a coiled coil in werner syndrome protein that facilitates multimerization and promotes exonuclease processivity. J Biol Chem 2010;285:25699-707.
40. Li B, Comai L. Functional interaction between Ku and the Werner syndrome protein in DNA end processing. J Biol Chem 2000;275:28349-52.
41. Cooper M, Machwe A, Orren D, Brosh R, Ramsden D, Bohr V. Ku complex interacts with and stimulates the Werner protein. Genes Dev 2000;14:907-12. (Pubitemid 30253000)
42. Beattie TL, Lees-Miller SP. Unraveling the roles of WRN and DNA-PKcs at telomeres. Aging (Albany NY) 2010;2:257-8.
43. Uziel O, Beery E, Dronichev V, Samocha K, Gryaznov S, Weiss L, et al. Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms. PLoS One 2010;5:e9132.
44. Deng Y, Chan SS, Chang S. Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer 2008;8:450-8. (Pubitemid 351744962)
45. Hagelstrom RT, Blagoev KB, Niedernhofer LJ, Goodwin EH, Bailey SM. Hyper telomere recombination accelerates replicative senescence and may promote premature aging. Proc Natl Acad Sci U S A 2010;107:15768-73.
46. Castedo M, Perfettini J, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004;23:2825-37. (Pubitemid 38638845)
47. Westendorf J, Rao P, Gerace L. Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. Proc Natl Acad Sci U S A 1994;91:714-8. (Pubitemid 24041472)
48. O'Sullivan-Coyne G, O'Sullivan G, O'Donovan T, Piwocka K, McKenna S. Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 2009;101:1585-95.
49. Tang M, Mah L, Vasireddy R, Georgiadis G, El-Osta A, Royce S, et al. Quantitation of gammaH2AX foci in tissue samples. J Vis Exp 2010;28:2063.
50. Sharma S, Brosh RM. Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges. PLoS One 2007;2:e1297.